| ID | 2113 |
| No | 2113 |
| Brand Name | STEI |
| Ingredients | BETAHISTINE DIHYDROCHLORIDE 8 MG. |
| Dosage Form | TABLET |
| Primary Packaging | ALU-PVC BLISTER |
| Storage | |
| Shelf Life | 3 YEARS AFTER MANUFACTURING DATE |
| Pack Size | BOX OF 10 X 10'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | VERTIGO,TINNITUS OR HEARING LOSS ASSOCIATED WITH MENIERE'S DISEASE.SYMPTOMATIC TREATMENT OF VESTIBULAR VERTIGO. |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE ROUND TABLET EMBOSSED WITH '' SPS'', ''S11'' AND BREAKLINE ON ONE SIDE AND EMBOSSED WITH “S” ON THE OTHER SIDE. |
| Note | |
| License Owner | PALAMY PHARMA CO., LTD |
| Manufacturer | SRIPRASIT PHARMA CO., LTD |
| Country | THAILAND |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 02 I 3835/13 |
| FDD Registration Date | 19/05/2023 |
| Expiry Date | 18/05/2026 |